This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 May 7;372(19):1854-6.

doi: 10.1056/NEJMe1502137. Epub 2015 Mar 14.

Balancing the risks and benefits of dual platelet inhibition

John F Keaney Jr¹

Affiliations

PMID: 25773507
DOI: 10.1056/NEJMe1502137

Editorial

Balancing the risks and benefits of dual platelet inhibition

John F Keaney Jr. N Engl J Med. 2015.

. 2015 May 7;372(19):1854-6.

doi: 10.1056/NEJMe1502137. Epub 2015 Mar 14.

Author

John F Keaney Jr¹

Affiliation

¹ From the Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester.

PMID: 25773507
DOI: 10.1056/NEJMe1502137

No abstract available

PubMed Disclaimer

Comment on

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM; DAPT Study Investigators. Mauri L, et al. N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16. N Engl J Med. 2014. PMID: 25399658 Free PMC article. Clinical Trial.
Long-term use of ticagrelor in patients with prior myocardial infarction.
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators. Bonaca MP, et al. N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14. N Engl J Med. 2015. PMID: 25773268 Clinical Trial.

Similar articles

Duration of dual antiplatelet therapy after drug-eluting stents.
Tomoda H. Tomoda H. N Engl J Med. 2015 Apr 2;372(14):1372-3. doi: 10.1056/NEJMc1501195. N Engl J Med. 2015. PMID: 25830434 No abstract available.
Duration of dual antiplatelet therapy after drug-eluting stents.
Pfisterer M, Kaiser C, Jeger R. Pfisterer M, et al. N Engl J Med. 2015 Apr 2;372(14):1372. doi: 10.1056/NEJMc1501195. N Engl J Med. 2015. PMID: 25830433 No abstract available.
Duration of dual antiplatelet therapy after drug-eluting stents.
Marrs JC. Marrs JC. N Engl J Med. 2015 Apr 2;372(14):1372. doi: 10.1056/NEJMc1501195. N Engl J Med. 2015. PMID: 25830432 No abstract available.
Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery.
Mahla E, Metzler H, Tantry US, Gurbel PA. Mahla E, et al. Ann Thorac Surg. 2010 Sep;90(3):1040-51. doi: 10.1016/j.athoracsur.2010.04.041. Ann Thorac Surg. 2010. PMID: 20732553 Review.
Aspirin and clopidogrel resistance: consideration and management.
Gurbel PA, Tantry US. Gurbel PA, et al. J Interv Cardiol. 2006 Oct;19(5):439-48. doi: 10.1111/j.1540-8183.2006.00181.x. J Interv Cardiol. 2006. PMID: 17020569 Review.

See all similar articles

Cited by

Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet Agents.
Xu J, Yan N, Wang C, Gao C, Han X, Yang C, Xu J, Wang K, Mitchell MJ, Zhang Y, Nie G. Xu J, et al. Circ Res. 2023 Feb 3;132(3):339-354. doi: 10.1161/CIRCRESAHA.122.321034. Epub 2023 Jan 10. Circ Res. 2023. PMID: 36625267 Free PMC article.
Temporal Trends of Bleeding Episodes during Half- vs. Standard-Dose Ticagrelor in Acute Coronary Syndrome Patients with Low Platelet Reactivity: A Randomized BLEEDING-ACS Trial.
Kim L, Choe JC, Ahn JH, Lee HW, Oh JH, Choi JH, Lee HC, Cha KS, Hong TJ, Jeong YH, Park JS. Kim L, et al. J Clin Med. 2021 Mar 10;10(6):1159. doi: 10.3390/jcm10061159. J Clin Med. 2021. PMID: 33802015 Free PMC article.
Risk definition and outcomes with the application of the PEGASUS-TIMI 54 trial inclusion criteria to a "real world" STEMI population: results from the Italian "CARDIO-STEMI SANREMO" registry.
Sanchez F, Boasi V, Vercellino M, Tacchi C, Cannarile P, Pingelli N, Perri D, Gomez L, Cattunar S, Mascelli G. Sanchez F, et al. BMC Cardiovasc Disord. 2021 Mar 18;21(1):144. doi: 10.1186/s12872-020-01780-y. BMC Cardiovasc Disord. 2021. PMID: 33736607 Free PMC article.
Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.
Pasea L, Chung SC, Pujades-Rodriguez M, Moayyeri A, Denaxas S, Fox KAA, Wallentin L, Pocock SJ, Timmis A, Banerjee A, Patel R, Hemingway H. Pasea L, et al. Eur Heart J. 2017 Apr 7;38(14):1048-1055. doi: 10.1093/eurheartj/ehw683. Eur Heart J. 2017. PMID: 28329300 Free PMC article.
Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
Cornel JH, Ohman EM, Neely B, Jakubowski JA, Bhatt DL, White HD, Ardissino D, Fox KA, Prabhakaran D, Armstrong PW, Erlinge D, Tantry US, Gurbel PA, Roe MT. Cornel JH, et al. J Am Heart Assoc. 2016 Nov 4;5(11):e003977. doi: 10.1161/JAHA.116.003977. J Am Heart Assoc. 2016. PMID: 27815268 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

R01 HL092122/HL/NHLBI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information